Stacey Curelop

Stacey Curelop has extensive work experience in the pharmaceutical industry. Stacey began their career at PPD as a Sr. CRA, where they monitored investigator conduct of clinical trials and negotiated trial agreements and budgets. Stacey then worked at Baldwin, MD & Baldwin, NP as the Director of Clinical Trials, managing all aspects of research and developing advertising campaigns. Stacey later joined InClin, Inc as a Lead / Sr CRA, acting as a primary liaison between sponsors, project teams, and vendors. During their time at InClin, they also worked as a Project Manager, aiding in the preparation of RFPs and developing project management plans. Stacey then moved to Viamet Pharmaceuticals, where they served as a Clinical Trial Manager. Most recently, they joined Mycovia Pharmaceuticals as the Director of Clinical Operations, overseeing clinical trial management.

Stacey Curelop holds a Master of Public Health (MPH) degree in Public Health, Epidemiology from San Jose State University, which they completed in 1997. Prior to that, they pursued a Bachelor of Arts (B.A.) degree at Pacific Union College, where their fields of study were French, Biology, and Music. In addition to their formal education, Stacey Curelop has obtained several certifications relevant to their field. These certifications include Basics of Signal Detection and Pharmacoepidemiology from the DIA (obtained in April 2022), Pre-Marketing Clinical Trial Safety from DIA Group (obtained in February 2022), Introduction to Drug Safety from DIA Group (obtained in October 2021), and Selecting and Managing Outsourced Safety Providers, also from DIA Group (obtained in March 2021).